Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection-Reference-Cited by-同舟云学术

Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection

Published:2017-12-29 Issue:4 Volume:65 Page:e26932
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Ronceray Leila¹,Abla Oussama²,Barzilai-Birenboim Shlomit³⁴,Bomken Simon⁵,Chiang Alan KS⁶,Jazbec Janez⁷,Kabickova Edita⁸,Lazic Jelena⁹,Beishuizen Auke¹⁰,Mellgren Karin¹¹,Tanaka Fumiko¹²,Pillon Marta¹³^ORCID,Devalck Christine¹⁴,Gouttenoire Marina¹⁵,Makarova Olga¹⁶,Burkhardt Birgit¹⁶,Attarbaschi Andishe¹^ORCID,

Affiliation:

1. Pediatric Hematology and Oncology; St. Anna Children's Hospital; Medical University of Vienna; Vienna Austria

2. Division of Hematology and Oncology; Department of Pediatrics; Hospital for Sick Children; Toronto Canada

3. Pediatric Hematology and Oncology; Schneider Children's Medical Center of Israel; Petah-Tivka Israel

4. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

5. Northern Institute for Cancer Research; Newcastle University; Newcastle UK

6. Department of Pediatrics and Adolescent Medicine; Li Ka Shing Faculty of Medicine; Queen Mary Hospital; The University of Hong Kong; Pokfulam Hong Kong

7. Division of Pediatrics; Hematology and Oncology; University Medical Center Ljubljana; Ljubljana Slovenia

8. Pediatric Hematology and Oncology; Charles University and University Hospital Motol; Prague Czech Republic

9. Pediatric Hematology and Oncology; University Children's Hospital; School of Medicine University of Belgrade; Belgrade Serbia

10. Pediatric Hematology and Oncology; Erasmus MC-Sophia Children's Hospital; Rotterdam The Netherlands

11. Pediatric Hematology and Oncology; The Queen Silvia's Hospital for Children and Adolescents; University of Göteborg; Göteborg Sweden

12. Department of Pediatrics; Saiseikai Yokohamashi Nanbu Hospital; Yokohama Japan

13. Pediatric Hematology and Oncology; University of Padova; Padova Italy

14. Pediatric Hematology and Oncology; Hopital Universitaire des Enfants Reine Fabiola; Brussels Belgium

15. Pediatric Hematology and Oncology; University Hospital; Saint Etienne France

16. Pediatric Hematology and Oncology; University of Münster; Münster Germany

Funder

Cancer Research UK

Forschungshilfe Station Peiper

St. Anna Kinderkrebsforschung

Czech Ministry of Health

Associazione Italiana Contro le Leucemie and Fondazione Citta della Speranza (AIEOP)

Ministry of Health, Labor, and Welfare of Japan (JPLSG)

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference19 articles.

1. The many faces of marginal zone lymphoma;Zinzani;Hematology Am Soc Hematol Educ Program,2012

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

3. Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma;Makarova;Br J Haematol,2017

4. Marginal zone B-cell lymphoma in children and young adults;Taddesse-Heath;Am J Surg Pathol,2003

5. Rare pediatric non-Hodgkin lymphomas: a report from Children's Oncology Group study ANHL 04B1;O'Suoji;Pediatr Blood Cancer,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Unusual Case of Extranodal Marginal Zone Lymphoma Mimicking Abdominal Cocoon Syndrome in an Adolescent Patient;Pediatric and Developmental Pathology;2023-10-30

2. Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma;Journal of Nuclear Medicine;2023-10-05

3. Extranodal marginal zone lymphoma as the presenting feature of paediatric Sjögren syndrome;Pediatric Blood & Cancer;2023-06-03

4. Diagnosis and management of rare paediatric Non-Hodgkin lymphoma;Best Practice & Research Clinical Haematology;2023-03

5. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma;The Lancet Haematology;2023-03